Dr. Sophia Frentzas
Claim this profileMonash Health
Studies Cancer
Studies Tumors
6 reported clinical trials
8 drugs studied
Area of expertise
1Cancer
Stage III
Stage IV
EGFR positive
2Tumors
Stage IV
Stage III
EGFR positive
Clinical Trials Sophia Frentzas is currently running
CLN-619 + Pembrolizumab
for Cancer
This trial is testing a new drug called CLN-619 alone and with pembrolizumab in patients with advanced solid tumors. These patients may not have other treatment options. Pembrolizumab helps the immune system fight cancer, and they are seeing if CLN-619 can help too.
Recruiting1 award Phase 110 criteria
TAK-280
for Advanced Cancer
The main aim of this study is to find out the safety, tolerability, and effect of TAK- 280 in participants with unresectable, locally advanced or metastatic cancer who have experienced treatment failure or are intolerant to standard therapies. Participants will be treated with TAK-280 for up to 14 treatment cycles. Each treatment cycle will be 28 days. After the last dose of study drug, participants will be followed up for survival every 12 weeks for a total of 48 weeks.
Recruiting1 award Phase 1 & 2
More about Sophia Frentzas
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sophia Frentzas has experience with
- AU-007
- Aldesleukin
- AK104
- TAK-186
- YL211
- TAK-280
Breakdown of trials Sophia Frentzas has run
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sophia Frentzas specialize in?
Sophia Frentzas focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is Sophia Frentzas currently recruiting for clinical trials?
Yes, Sophia Frentzas is currently recruiting for 5 clinical trials in Clayton Victoria. If you're interested in participating, you should apply.
Are there any treatments that Sophia Frentzas has studied deeply?
Yes, Sophia Frentzas has studied treatments such as AU-007, Aldesleukin, AK104.
What is the best way to schedule an appointment with Sophia Frentzas?
Apply for one of the trials that Sophia Frentzas is conducting.
What is the office address of Sophia Frentzas?
The office of Sophia Frentzas is located at: Monash Health, Clayton, Victoria 3168 Australia. This is the address for their practice at the Monash Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.